Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VISIOPHARM A/S
A/S
Active
CVR 26186676
Agern Alle 24, 2970
Hørsholm
Computer consultancy and computer facilities management activities
·
NACE 6220
Est. 2001 · 24 years old
59 employees
Monitor
Share
Denmark
/
Companies
/
Computer consultancy and computer facilities management activities
/
VISIOPHARM A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
39M
78M
117M
156M
108M
2021
136M
2022
112M
2023
118M
2024
131M
2025
EBITDA
DKK millions
0M
-12M
-24M
-36M
-48M
-38M
2021
-19M
+50%
2022
-14M
+26%
2023
-2M
+86%
2024
-2M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
108.495
135.974
112.093
118.186
130.617
Staff expenses
-83.742
-72.620
-78.395
-73.425
-72.974
EBITDA
-38.464
-19.068
-14.496
-2.391
-2.486
Depreciation & amort.
-7.759
-8.737
-9.585
-9.989
-9.314
EBIT
-46.223
-27.805
-24.081
-12.380
-11.800
Net financials
-512
3.478
-4.447
-5.084
-6.183
Profit before tax
-46.735
-24.327
-28.528
-17.464
-17.983
Tax
-5.394
-3.715
1.760
-101
-760
Net profit
-41.341
-20.612
-30.288
-17.363
-17.223
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
133.560
107.596
128.996
118.419
97.853
Equity
59.406
33.904
25.482
9.155
-4.949
Long-term debt
4.233
19.341
41.794
36.237
32.332
Short-term debt
69.921
54.351
61.720
73.027
70.470
Total debt
74.154
73.692
103.514
109.264
102.802
Financial ratios
5-year trend
EBITDA margin
-1.9%
This company
15.8%
Market median
-112% vs market
2021
2025
Equity ratio
-5.1%
This company
38.2%
Market median
-113% vs market
2021
2025
Return on equity
-1722300000.0%
This company
18.4%
Market median
-9360326187% vs market
2021
2025
Net profit margin
-13.2%
This company
8.1%
Market median
-263% vs market
2021
2025
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
2021
2025
Debt / equity
20.77×
This company
0.62×
Market median
-3250% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on VISIOPHARM A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
